Member Info for mikem004

Looks like a very hefty share dilution. What do people here think? Will the SP recover in the medium term?

Someone at the Daily Telegraph can't spell Morrison's. That doesn't inspire confidence in the rest of the article.

Might as well sell my MRW shares and move on. Offer is 252 + 2p special dividend.
Open market is 260 ish.
Originally bought at 192 a few years back, as a reliable dividend share. With the outside chance of a takeover due to all the land that MRW owns. But I expected a higher offer if that ever happened!

Good point. Commercial property prices are depressed at the moment.
But surely freehold land will always be in demand in the UK?

The property portfolio alone is worth 8 billion UKP = 11 billion USD.
On that metric alone, the bids so far are seriously undervaluing Morrisons.

Seems a low bid to accept, when you consider the freehold property portfolio that MRW has.
Not exactly maximizing shareholder value, is it?

The bid is too low.
MRW has £6 billion worth of freehold property. Add on one of the top four supermarket businesses in the UK, and you can see why the bid has been rejected by the board.

+31%, 2x average volume traded
Summit is being noticed, it seems.

Re: Mention of Reddit.
I don't think SMMT is a share that has a lot of short positions, so it probably wouldn't interest the anti-Wall Street people:
https://docoh.com/company/1599298/SMMT/short-interest

Ignore last post. Wrong thread, my apologies.

>The AstraZeneca vaccine is cost neutral.<
If that is true, then AZN has no incentive to get their supply issues fixed quickly.
It won't affect their bottom line.

>The AstraZeneca vaccine is cost neutral.<
If that is true, then AZN has no incentive to get their supply issues fixed quickly.
It won't affect their bottom line.

AstraZeneca to cut Covid-19 vaccine delivery to EU by 60 per cent:
https://uk.yahoo.com/news/astrazeneca-cut-covid-19-vaccine-224149269.html

I don't know who has handled the public relations for the AZN trial, but they haven't done a very good job.
The message coming out is: "only 60%", "90% discovered by accident due to a mess up".
The message coming out should be: "up to 90%", "cheap as a cup of coffee", "can be distributed using a supermarket logistics chain" etc.

I am starting to think that the "low cost" aspect has caused the SP drop.
The markets may prefer the more expensive "designer drug" solutions from Pfizer and Moderna.

I stopped reading after the first paragraph...
Lets keep it related to AZN, please.

Surely the market recognise that AZN have a traditional vaccine, which is easy and cheap to deploy?
Moderna and Pfizer's vaccine uses bleeding edge technology, which is expensive and has not been safely tested on a population.

OK, thanks. So it's related to the takeover.
I had expected COVID-sensitive stocks such as airlines, pharma etc. to be most highly shorted.

This was a surprise to me:
https://uk.finance.yahoo.com/news/cineworld-among-10-most-shorted-uk-stocks-112811658.html
"After Cineworld, the next most shorted UK-listed company was Premier Oil PLC (PMO.L), whose short position was 9.14%, following by Tullow Oil PLC (TLW.L) and Petrofac LTD (PFC.L)."

16 times the normal volume traded yesterday, up 18%.
Have they discovered a new vaccine or something ?!